{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:15:11Z","timestamp":1795119311452,"version":"4.10.3"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Cardiogenic shock presents with variable severity. Categorizing cardiogenic shock into clinical stages may improve risk stratification and patient selection for therapies. We sought to determine whether a structured implementation of the 2019 Society for Cardiovascular Angiography and Interventions clinical cardiogenic shock staging criteria that is ascertainable in clinical registries discriminates mortality in a contemporary population with or at-risk for cardiogenic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>We developed a pragmatic application of the Society for Cardiovascular Angiography and Interventions cardiogenic shock staging criteria\u2014A (at-risk), B (beginning), C (classic cardiogenic shock), D (deteriorating), or E (extremis)\u2014and examined outcomes by stage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>The Critical Care Cardiology Trials Network is an investigator-initiated multicenter research collaboration coordinated by the TIMI Study Group (Boston, MA). Consecutive admissions with or at-risk for cardiogenic shock during two annual 2-month collection periods (2017\u20132019) were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients with or at-risk for cardiogenic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Of 8,240 CICU admissions reviewed, 1,991 (24%) had or were at-risk for cardiogenic shock. Distributions across the five stages were as follows: A: 33%; B: 7%; C: 16%; D: 23%; and E: 21%. Overall in-hospital mortality among patients with established cardiogenic shock was 39%; however, mortality varied from only 15.8% to 32.1% to 62.5% across stages C, D, and E (Cochran-Armitage <jats:italic toggle=\"yes\">p<\/jats:italic>\n                                 <jats:sub>trend<\/jats:sub> &lt; 0.0001). The Society for Cardiovascular Angiography and Interventions stages improved mortality prediction beyond the Sequential Organ Failure Assessment and Intra-Aortic Balloon Pumpin Cardiogenic Shock II scores.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Although overall mortality in cardiogenic shock remains high, it varies considerably based on clinical stage, identifying stage C as relatively lower risk. We demonstrate a pragmatic adaptation of the Society for Cardiovascular Angiography and Interventions cardiogenic shock stages that effectively stratifies mortality risk and could be leveraged for future clinical research.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000004948","type":"journal-article","created":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T23:00:52Z","timestamp":1617577252000},"page":"1293-1302","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":93,"title":["The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry"],"prefix":"10.1097","volume":"49","author":[{"given":"Patrick R.","family":"Lawler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Berg","sequence":"additional","affiliation":[{"name":"Levine Cardiac Intensive Care Unit, TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Gun","family":"Park","sequence":"additional","affiliation":[{"name":"Levine Cardiac Intensive Care Unit, TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason N.","family":"Katz","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Duke University, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian M.","family":"Baird-Zars","sequence":"additional","affiliation":[{"name":"Levine Cardiac Intensive Care Unit, TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Barsness","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin A.","family":"Bohula","sequence":"additional","affiliation":[{"name":"Levine Cardiac Intensive Care Unit, TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Carnicelli","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunit-Preet","family":"Chaudhry","sequence":"additional","affiliation":[{"name":"Department of Cardiology, St. Vincent Hospital, Indianapolis, IN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob C.","family":"Jentzer","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN."},{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venu","family":"Menon","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Metkus","sequence":"additional","affiliation":[{"name":"John Hopkins University, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Nativi-Nicolau","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, UT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Phreaner","sequence":"additional","affiliation":[{"name":"University of California San Diego, San Diego, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank S.","family":"Sinha","sequence":"additional","affiliation":[{"name":"Inova Heart and Vascular Institute, Inova Fairfax Medical Center, Falls Church, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Teuteberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"van Diepen","sequence":"additional","affiliation":[{"name":"Departments of Critical Care and Medicine (Cardiology), University of Alberta, Edmonton, AB, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Morrow","sequence":"additional","affiliation":[{"name":"Levine Cardiac Intensive Care Unit, TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: A scientific statement from the American Heart Association.","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"e000590","DOI":"10.1161\/JAHA.113.000590","article-title":"Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States.","volume":"3","author":"Kolte","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jcin.2015.10.039","article-title":"Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: A report from the CathPCI registry.","volume":"9","author":"Wayangankar","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.108.814947","article-title":"Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective.","volume":"119","author":"Goldberg","year":"2009","journal-title":"Circulation"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock.","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock.","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/eurheartj\/ehp292","article-title":"Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: A meta-analysis of controlled trials.","volume":"30","author":"Cheng","year":"2009","journal-title":"Eur Heart J"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","article-title":"Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction.","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.297.15.joc70035","article-title":"Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: The TRIUMPH randomized controlled trial.","volume":"297","author":"Alexander","year":"2007","journal-title":"JAMA"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","article-title":"Why have clinical trials in sepsis failed?","volume":"20","author":"Marshall","year":"2014","journal-title":"Trends Mol Med"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis.","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S2213-2600(18)30287-X","article-title":"Heterogeneity and phenotypic stratification in acute respiratory distress syndrome.","volume":"6","author":"Lawler","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","article-title":"Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trial.","volume":"199","author":"Antcliffe","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: Secondary analysis of a randomised controlled trial.","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/CCM.0b013e31819d5db1","article-title":"Predisposition, insult\/infection, response, and organ dysfunction: A new model for staging severe sepsis.","volume":"37","author":"Rubulotta","year":"2009","journal-title":"Crit Care Med"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.healun.2018.07.009","article-title":"Advancing from a \u201chemodynamic model\u201d to a \u201cmechanistic disease-modifying model\u201d of cardiogenic shock.","volume":"37","author":"Lawler","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019.","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2019.07.077","article-title":"Cardiogenic shock classification to predict mortality in the cardiac intensive care unit.","volume":"74","author":"Jentzer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"E213","DOI":"10.1002\/ccd.28707","article-title":"Application of the SCAI classification in a cohort of patients with cardiogenic shock.","volume":"96","author":"Schrage","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/jamacardio.2019.2467","article-title":"Demographics, care patterns, and outcomes of patients admitted to cardiac intensive care units: The critical care cardiology trials network prospective north American multicenter registry of cardiac critical illness.","volume":"4","author":"Bohula","year":"2019","journal-title":"JAMA Cardiol"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine.","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2017.02.027","article-title":"Risk stratification for patients in cardiogenic shock after acute myocardial infarction.","volume":"69","author":"P\u00f6ss","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"e006635","DOI":"10.1161\/CIRCHEARTFAILURE.119.006635","article-title":"Clinical practice patterns in temporary mechanical circulatory support for shock in the Critical Care Cardiology Trials Network (CCCTN) Registry.","volume":"12","author":"Berg","year":"2019","journal-title":"Circ Heart Fail"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"e005618","DOI":"10.1161\/CIRCOUTCOMES.119.005618","article-title":"Epidemiology of shock in contemporary cardiac intensive care units.","volume":"12","author":"Berg","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4161\/viru.26908","article-title":"The PIRO (predisposition, insult, response, organ dysfunction) model: Toward a staging system for acute illness.","volume":"5","author":"Marshall","year":"2014","journal-title":"Virulence"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1186\/cc3907","article-title":"The staging of sepsis: Understanding heterogeneity in treatment efficacy.","volume":"9","author":"Marshall","year":"2005","journal-title":"Crit Care"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jacc.2016.10.025","article-title":"Mechanical support for cardiogenic shock: Lost in translation?","volume":"69","author":"Zeymer","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cjca.2019.11.030","article-title":"What is the role of medical therapy in cardiogenic shock in the era of mechanical circulatory support?","volume":"36","author":"van Diepen","year":"2020","journal-title":"Can J Cardiol"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"Complete revascularization with multivessel PCI for myocardial infarction.","volume":"381","author":"Mehta","year":"2019","journal-title":"N Engl J Med"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: Next steps in clinical translation.","volume":"42","author":"Lawler","year":"2020","journal-title":"Eur Heart J"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/CCM.0b013e318168ea3e","article-title":"Multicenter, randomized, controlled trials evaluating mortality in intensive care: Doomed to fail?","volume":"36","author":"Ospina-Tasc\u00f3n","year":"2008","journal-title":"Crit Care Med"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"e197229","DOI":"10.1001\/jamanetworkopen.2019.7229","article-title":"Association of surrogate decision-making interventions for critically ill adults with patient, family, and resource use outcomes: A systematic review and meta-analysis.","volume":"2","author":"Bibas","year":"2019","journal-title":"JAMA Netw Open"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:12:43Z","timestamp":1746205963000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000004948","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,2]]}}}